Letter by Salata et al Regarding Article, "Utilization of Advanced Cardiovascular Therapies in the United States and Canada: An Observational Study of New York and Ontario Administrative Data"
- PMID: 32366115
- DOI: 10.1161/CIRCOUTCOMES.120.006569
Letter by Salata et al Regarding Article, "Utilization of Advanced Cardiovascular Therapies in the United States and Canada: An Observational Study of New York and Ontario Administrative Data"
Comment in
-
Response by Cram et al to Letter Regarding Article, "Utilization of Advanced Cardiovascular Therapies in the United States and Canada: An Observational Study of New York and Ontario Administrative Data".Circ Cardiovasc Qual Outcomes. 2020 May;13(5):e006587. doi: 10.1161/CIRCOUTCOMES.120.006587. Epub 2020 May 5. Circ Cardiovasc Qual Outcomes. 2020. PMID: 32366114 Free PMC article. No abstract available.
-
Response by Hoque et al to Letter Regarding Article, "SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation".Circ Cardiovasc Qual Outcomes. 2020 May;13(5):e006671. doi: 10.1161/CIRCOUTCOMES.120.006671. Epub 2020 May 7. Circ Cardiovasc Qual Outcomes. 2020. PMID: 32375503 Free PMC article. No abstract available.
Comment on
-
Utilization of Advanced Cardiovascular Therapies in the United States and Canada: An Observational Study of New York and Ontario Administrative Data.Circ Cardiovasc Qual Outcomes. 2020 Jan;13(1):e006037. doi: 10.1161/CIRCOUTCOMES.119.006037. Epub 2020 Jan 20. Circ Cardiovasc Qual Outcomes. 2020. PMID: 31957474 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
